| Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission T Tabata, M Petitt, H Puerta-Guardo, D Michlmayr, C Wang, ... Cell host & microbe 20 (2), 155-166, 2016 | 539 | 2016 |
| Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination PR Beatty, H Puerta-Guardo, SS Killingbeck, DR Glasner, K Hopkins, ... Science translational medicine 7 (304), 304ra141-304ra141, 2015 | 523 | 2015 |
| Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability H Puerta-Guardo, DR Glasner, E Harris PLoS pathogens 12 (7), e1005738, 2016 | 332 | 2016 |
| Flavivirus NS1 triggers tissue-specific vascular endothelial dysfunction reflecting disease tropism H Puerta-Guardo, DR Glasner, DA Espinosa, SB Biering, M Patana, ... Cell reports 26 (6), 1598-1613. e8, 2019 | 242 | 2019 |
| Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components. DR Glasner, K Ratnasiri, H Puerta-Guardo, DA Espinosa, PR Beatty, ... Plos pathogens 13 (11), e1006673, 2017 | 181 | 2017 |
| The good, the bad, and the shocking: the multiple roles of dengue virus nonstructural protein 1 in protection and pathogenesis DR Glasner, H Puerta-Guardo, PR Beatty, E Harris Annual review of virology 5 (1), 227-253, 2018 | 171 | 2018 |
| Longitudinal analysis of antibody cross-neutralization following Zika virus and dengue virus infection in Asia and the Americas M Montoya, M Collins, W Dejnirattisai, LC Katzelnick, H Puerta-Guardo, ... The Journal of infectious diseases 218 (4), 536-545, 2018 | 158 | 2018 |
| The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity R Soto-Acosta, C Mosso, M Cervantes-Salazar, H Puerta-Guardo, ... Virology 442 (2), 132-147, 2013 | 145 | 2013 |
| Structural basis for antibody inhibition of flavivirus NS1–triggered endothelial dysfunction SB Biering, DL Akey, MP Wong, WC Brown, NTN Lo, H Puerta-Guardo, ... Science 371 (6525), 194-200, 2021 | 88 | 2021 |
| Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains H Puerta-Guardo, C Mosso, F Medina, F Liprandi, JE Ludert, ... Journal of General Virology 91 (2), 394-403, 2010 | 81 | 2010 |
| Transmigration of neural stem cells across the blood brain barrier induced by glioma cells M Diaz-Coranguez, J Segovia, A Lopez-Ornelas, H Puerta-Guardo, ... PloS one 8 (4), e60655, 2013 | 76 | 2013 |
| Zika Virus Replicates in Proliferating Cells in Explants from First-trimester Human Placentas, Potential Sites for Dissemination of Infection. T Takako, M Petitt, H Puerta-Guardo, D Michlmayr, E Harris, L Pereira Journal of Infectious Diseases, 2017 | 71 | 2017 |
| Endocytosis of flavivirus NS1 is required for NS1-mediated endothelial hyperpermeability and is abolished by a single N-glycosylation site mutation C Wang, H Puerta-Guardo, SB Biering, DR Glasner, EB Tran, M Patana, ... PLoS pathogens 15 (7), e1007938, 2019 | 65 | 2019 |
| The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular … H Puerta-Guardo, A Raya-Sandino, L González-Mariscal, VH Rosales, ... Journal of virology 87 (13), 7486-7501, 2013 | 63 | 2013 |
| The 1α, 25-dihydroxy-vitamin D3 reduces dengue virus infection in human myelomonocyte (U937) and hepatic (Huh-7) cell lines and cytokine production in the infected monocytes H Puerta-Guardo, SI De la Cruz Hernández, VH Rosales, JE Ludert, ... Antiviral research 94 (1), 57-61, 2012 | 58 | 2012 |
| Primary dengue virus infections induce differential cytokine production in Mexican patients SI de la Cruz Hernández, HN Puerta-Guardo, H Flores Aguilar, ... Memorias do Instituto Oswaldo Cruz 111, 161-167, 2016 | 47 | 2016 |
| A strong interferon response correlates with a milder dengue clinical condition SIDLC Hernández, H Puerta-Guardo, H Flores-Aguilar, ... Journal of Clinical Virology 60 (3), 196-199, 2014 | 44 | 2014 |
| Zika virus nonstructural protein 1 disrupts glycosaminoglycans and causes permeability in developing human placentas H Puerta-Guardo, T Tabata, M Petitt, M Dimitrova, DR Glasner, L Pereira, ... The Journal of infectious diseases 221 (2), 313-324, 2020 | 41 | 2020 |
| Magnitude and functionality of the NS1-specific antibody response elicited by a live-attenuated tetravalent dengue vaccine candidate M Sharma, DR Glasner, H Watkins, H Puerta-Guardo, Y Kassa, MA Egan, ... The Journal of infectious diseases 221 (6), 867-877, 2020 | 40 | 2020 |
| Pilot trial using mass field-releases of sterile males produced with the incompatible and sterile insect techniques as part of integrated Aedes aegypti control in Mexico A Martín-Park, A Che-Mendoza, Y Contreras-Perera, S Pérez-Carrillo, ... PLOS Neglected Tropical Diseases 16 (4), e0010324, 2022 | 34 | 2022 |
